摘要
Sox(与SPY相关的HMG盒)家族基因是细胞生长、平衡、再生中重要的调节物质。Sox家族基因某种成员的重整已经被应用于许多包括恶性毒瘤在内人类恶性肿瘤。越来越多的证据表明Sox基因在恶性毒瘤细胞发病机理、生长和增殖方面起着重要的作用。在此,我们综述了基因Sox2 和Sox9在骨肉瘤、软骨肉瘤、脊索瘤,基因Sox2、Sox6和Sox17在尤因肉瘤,基因 Sox2、Sox9和Sox10在滑膜肉瘤,基因Sox2在纤维肉瘤以及Sox21在脂肪肉瘤方面的的生物相关性。这些发现增强了Sox基因在肉瘤方面靶向新型干预治疗的作用,也表现出提高关注肉瘤患者有价值的临床治疗可能性。
关键词: Sox 家族基因;恶性肿瘤;发病机理;靶向治疗
图形摘要
Current Drug Targets
Title:The Roles of Sox Family Genes in Sarcoma
Volume: 17 Issue: 15
Author(s): Jingyuan Li, Jacson Shen, Kunzheng Wang, Francis Hornicek, Zhenfeng Duan
Affiliation:
关键词: Sox 家族基因;恶性肿瘤;发病机理;靶向治疗
摘要: Sox (SRY-related HMG-box) family genes are important regulators of cell development, homeostasis, and regeneration. Deregulation of certain members of the Sox gene family has been implicated in a number of human malignancies, including in sarcoma. Accumulating evidence suggests that Sox genes play crucial roles in sarcoma cell pathogenesis, growth, and proliferation. Here, we review the biological relevance of Sox2 and Sox9 genes in osteosarcoma, chondrosarcoma and chordoma; Sox2, Sox6, and Sox17 genes in Ewing’s sarcoma; Sox2, Sox9, and Sox10 genes in synovial sarcoma; Sox2 gene in fibrosarcoma; and Sox21 gene in liposarcoma. These findings potentiate the targeting of Sox genes for novel therapeutic interventions in sarcoma and may also hold valuable clinical potential to improve the care of patients with sarcoma.
Export Options
About this article
Cite this article as:
Jingyuan Li, Jacson Shen, Kunzheng Wang, Francis Hornicek, Zhenfeng Duan , The Roles of Sox Family Genes in Sarcoma, Current Drug Targets 2016; 17 (15) . https://dx.doi.org/10.2174/1389450117666160502145311
DOI https://dx.doi.org/10.2174/1389450117666160502145311 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diketo Acids Derivatives as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain
Current Medicinal Chemistry Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers
Recent Patents on CNS Drug Discovery (Discontinued) Bergenin - A Biologically Active Scaffold: Nanotechnological Perspectives
Current Topics in Medicinal Chemistry Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma
Current Drug Therapy The ALK Gene, An Attractive Target for Inhibitor Development
Current Topics in Medicinal Chemistry Mining the Adenovirus "Virome" for Systemic Oncolytics
Current Pharmaceutical Biotechnology Recent Advances in the Development of Thalidomide-Related Compounds as Anticancer Drugs
Current Medicinal Chemistry Targeted Therapy for Brain Tumours: Role of PARP Inhibitors
Current Cancer Drug Targets Concurrence of Talaromycosis and Kaposi Sarcoma in an HIV-Infected Patient: A Case Report
Current HIV Research VEGF Inhibitors in Cancer Therapy
Current Pharmaceutical Design The Retinoblastoma Protein in Osteoblast Differentiation and Osteosarcoma
Current Molecular Medicine BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile
Current Medicinal Chemistry Review of Structures Containing Fullerene-C60 for Delivery of Antibacterial Agents. Multitasking model for Computational Assessment of Safety Profiles
Current Bioinformatics Signal Transduction and Heavy Ion Radiation Therapy: Biological Mechanisms, Biological Quality Assurance, and New Multimodality Approach
Current Signal Transduction Therapy Recurrence in Bladder Cancer: A Molecular Dead End?
Current Genomics Cancer Resistance to Type II Topoisomerase Inhibitors
Current Medicinal Chemistry Monoclonal Antibodies in the Management of Solid Tumors
Current Topics in Medicinal Chemistry Kinase Inhibitors Targeting Anti-angiogenesis as Anti-cancer Therapies
Current Angiogenesis (Discontinued) TNF α Signaling Beholds Thalidomide Saga: A Review of Mechanistic Role of TNF-α Signaling Under Thalidomide
Current Topics in Medicinal Chemistry Seek and Destroy: The Use of Natural Compounds for Targeting the Molecular Roots of Cancer
Current Drug Targets